The tumor-bearing state is known to induce immune dysfunction that contributes to increased infectious complications and tumor progression. However, the mechanisms underlying this immunosuppression remain unclear.
T
HE INCIDENCE of melanoma has increased dramatically over the last few decades among white populations. [1] [2] [3] Noveltherapeuticapproaches are being tested based on better understanding of the immune response to melanoma and the isolation of melanoma-specific antigens. 4, 5 However, clinical responses have been less than encouraging. Further refinement in our understanding of melanoma immunology is needed, 6, 7 specifically of the mechanisms involved in immunosuppression induced by melanoma and other tumors. This immunosuppression may account for the host's inability to respond to immunotherapeutic protocols and increased incidence of infectious complications in addition to continued tumor growth. 8, 9 The macrophage (MO) plays an important role in the immune response to pathogens and tumors, and is one of the first cell populations to appear with neutrophils in the acute phase of the inflammatory response. Macrophage-mediated tumor killing and killing of intracellular organisms has been shown to be dependent on the elaboration of reactive intermediates such as nitric oxide (NO), superoxide (SO) anion, and cytokines such as tumor necrosis factor ␣ (TNF-␣). [10] [11] [12] [13] Conversely, the production of prostaglandin E 2 (PGE 2 ) has been shown to be associated with immunosuppressive states and decreased MO effector functions. 14 The purpose of this study was to examine the effect of B16 melanoma growth on peritoneal MO (PMO) function in melanoma-bearing mice.
RESULTS

TUMOR MODEL CHARACTERISTICS
The inoculation of B16 subcutaneously into C57BL/6 mice resulted in progressive tumor growth. No differences in food intake between the groups were noted during the study period. Mean food intake during the study period averaged 2.9 ± 0. 3 mice. Mice were euthanized 3 weeks after tumor inoculation and the time points were chosen to ensure that all animals in the study had palpable tumors. At the time of euthanization the mean tumor volume was 3.2±0.8 cm 3 .
MELANOMA GROWTH INHIBITS PMO NO PRODUCTION
To determine the effects of progressive melanoma growth on PMO NO production, PMOs from control and B16 melanoma-bearing mice were stimulated with LPS (1 µg/mL) and interferon gamma (100 U/mL) for 72 hours and NO production was measured. Figure 1 shows PMOs from B16 melanoma-bearing mice with significantly less mean NO production compared with controls (4.4±1.4 vs 24.6±0.7 nM/2 ϫ10 5 MO; PϽ.001). The decreased ability of PMOs from melanoma-bearing mice to produce NO was not owing to decreased viability, since PMOs from control and melanoma-bearing mice had similar viability on the results of trypan blue dyeexclusion tests and the methylthiotetrazole viability assay (not shown).
MATERIALS AND METHODS
TUMOR
The B16 melanoma tumor line was derived from a malignant melanoma that arose spontaneously in C57BL/6 mice at the Jackson Laboratories (Bar Harbor, Me). This tumor was obtained from the Tumor Depository, Division of Cancer Treatment, National Cancer Institute (Frederick, Md) and is characterized as being nonimmunogenic. The B16 cell lines were free of mycoplasma (tested by ATCC, Rockville, Md) and free of the following viruses and microorganisms: pneumonia virus of mice, Sendai, mouse hepatitis virus, Theiler, minute virus of mice, parvovirus, lymphocytic choriomeningitis, epizootic diarrhea of infant mice, lactate dehydrogenase-elevating virus, reo type 3, polyoma, ectromelia, K virus, mouse adenovirus, mouse cytomegalovirus, Mycoplasma pulmonis, and cilium-associated respiratory bacillus (tested byMicrobiologicalAssociates,Rockville).Thecellsweregrown in vitro in Dulbecco Modified Eagle Medium (high glucose) supplemented with 10% fetal calf serum (Hyclone, Logan, Utah), 2mM of glutamine, 100 U/mL of penicillin G sodium, 100 µg/mL of streptomycin sulfate, 0.25 µg/mL of amphotericin B, and 50µM 2-mercaptoethanol in 6% carbon dioxide to 95% air at 37°C. Cells were passaged biweekly by removing the old medium, rinsing the cells with Hank balanced salt solution (HBSS) (calcium-and magnesium-free), and briefly exposing them to 0.05% trypsin in 0.53mM edetic acid solution at 37°C for 2 to 3 minutes. The flask was tapped sharply against a solid surface to dislodge the cells, Dulbecco Modified Eagle Medium was added, and the cell suspension was repeatedly pipetted to produce a single cell suspension.
ANIMALS
Virus-free female C57BL/6 mice aged 8 to 12 weeks (average weights, 20-22 g) were purchased from Charles Rivers Laboratories (Wilmington, Mass). Mice were given food and water ad libitum and given a week to acclimate before being used in experiments. For in vivo tumor studies, mice (n=20) were randomized to receive melanoma cells (5ϫ10 5 B16 cells) subcutaneously into the interscapular region (n=10) or to receive HBSS injection only (control mice) (n=10). Body weight and food intake were measured on alternate days. Measurements of tumor size (longest and shortest diameters) were done biweekly from the time tumors became palpable using electronic digital calipers (Fowler Ultra-cal II; Sylvac, Switzerland). ). This technique has proved to be a reliable measure of tumor volume in many previous studies and to correlate closely with tumor weight. 15 Mice were housed in a facility approved by the American Association for Accreditation of Laboratory AnimalCare(WeillMedicalCollege,CornellUniversity,NewYork, NY), and all animal protocols were approved by the Institutional Animal Care and Use Committee at Weill Medical College of Cornell University.
HARVESTING OF PERITONEAL EXUDATE CELLS
Elicited PMOs were obtained by injecting mice with 2 mL of 4% thioglycollate solution intraperitoneally 4 days prior to euthanization. Mice were killed by carbon dioxide (CO 2 ) asphyxiation and the peritoneum was exposed. Ten milliliters of cold sterile HBSS (calcium-and magnesium-free) was injected intraperitoneally. The solution was agitated in the peritoneal cavity for 1 minute and aspirated. The aspirate was centrifuged at 200g for 10 minutes at 4°C. The supernatant was decanted, the pellet was resuspended in HBSS, and the cells were counted. Viability (trypan blue exclusion) was usually 95% to 100%. The cells were adjusted to a final concentration of 106 cells/mL. Peritoneal exudate cells were plated, depending on the experiment, in 24-or 96-well plates and incubated for 2 hours in 6% CO 2 /95% room air at 37°C. Nonadherent cells were aspirated and adherent cells were washed twice with HBSS. This protocol yielded a greater than 90% pure PMO population as documented by morphological and fluorescent-activated cell sorter analysis using MO-specific F4/80 monoclonal antibody (Harlan, Indianapolis, Ind). All MO studies were performed in Dulbecco Modified Eagle Medium (high glucose) supplemented with 3% fetal calf serum (Hyclone), 2 mM of glutamine, 100 U/mL of penicillin, 100 µg/mL of streptomycin, 0.25 µg/mL of amphotericin B, and 50µM of 2-ME in 6% CO 2 /95% room air at 37°C. This complete medium was tested for endotoxins using the chromogenic Limulus Amebocyte Lysate assay (BioWhittaker, Walkersville, Md) and was found to contain an endotoxin concentration of less than 0.2 E U/mL.
STIMULATION FOR NO PRODUCTION AND NITRITE MEASUREMENT
Adherent PMOs (2ϫ10 5 per well) were stimulated with lipopolysaccharide (LPS) (1 µg/mL) and interferon gamma (100 U/mL). Preliminary studies demonstrated that these concentrations stimulate maximal NO production under the experimental conditions used. Seventy-two hours later supernatants were removed and assayed for NO production 
MELANOMA GROWTH INHIBITS PMO SO ANION PRODUCTION
To determine the effects of melanoma growth on PMO SO anion production, PMOs from control and B16 melanoma-bearing mice were stimulated with PMA (1 mg/ mL) for 90 minutes and SO anion production was measured. Figure 2 shows that PMOs from B16 melanomabearing mice had significantly less mean SO anion production compared with controls (0.11 ± 0.08 vs 0.31±0.05 nM/2ϫ 10 5 MO; PϽ.01). These data indicate that PMOs from melanoma-bearing mice had a significant decrease in SO anion production.
MELANOMA GROWTH INHIBITS PMO TNF-␣ PRODUCTION
To determine the effects of melanoma growth on PMO TNF-␣ production, PMOs from control and B16 melanoma-bearing mice were stimulated with LPS (1 µg/ by measuring the accumulation of nitrite in supernates using the Griess reaction as described previously. 16 Briefly, in a 96-well plate, 100 µL of medium was mixed with 100 µg of an equal mixture of 1% sulfanilamide and 0.1% naphthylethelenediamine dihydrochloride in 2.5% phosphoric acid and incubated at room temperature for 10 minutes. Absorbance at 550 nm was measured using a UVmax microplate reader (Molecular Devices, Menlo Park, Calif) and data were calculated by comparison to standard curves generated using sodium nitrite standards.
SO ANION MEASUREMENTS
Superoxide anion was assayed according to the method of Pick and Mizel as the superoxide dismutase-inhibitable reduction of cytochrome c method. 17 Adherent PMOs (2ϫ10 5 per well) in 96-well flat-bottom plates were incubated with a 160µM solution of ferricytochrome c in phenol red-free HBSS alone, with superoxide dismutase (300 U/mL), or with a stimulus (1-mg/mL phorbol myristate acetate [PMA]). Plates were incubated at 37°C for 90 minutes. Absorbance at 550 nm was measured using a microplate reader. Values (mean of triplicate wells) were converted to nanomoles of SO anion per 2ϫ10 5 cells per 90 minutes based on the extinction coefficient of (reduced minus oxidized) cytochrome c.
TNF-␣ ENZYME-LINKED IMMUNOSORBENT ASSAY
Adherent PMOs (2ϫ10 5 per well) were stimulated with 1 µg/mL of LPS and supernates were harvested 24 hours later. Tumor necrosis factor ␣ was measured by enzyme-linked immunosorbent assay using specific antibody pairs according to the manufacturer's recommendation (Phamingen, San Diego, Calif). Plates were read in a microplate reader, unknown values were calculated by extrapolation from standard curves generated using recombinant TNF-␣, and analysis was performed using Delta Soft (Biometallics Inc, Princeton, NJ) analysis software on a Macintosh (Apple Inc, Cupertino, Calif) computer.
PGE 2 ASSAYS
Adherent PMOs (2ϫ10 5 per well) were stimulated with 1 µg/mL of LPS and supernates were harvested 24 hours later. Prostaglandin E 2 levels were assayed using an enzyme immunoassay kit according to the manufacturer's protocol (Cayman, Ann Arbor, Mich).
MO CANDIDACIDAL ACTIVITY
Macrophage-mediated candidacidal assay was performed according to the method of Cenci et al. 18 Adherent PMOs (2ϫ10 5 per well) were incubated with Candida albicans in 96-well flat-bottom plates at an MO to Candida ratio of 10:1 at 37°C. After 4 hours of incubation, Triton X-100 (Sigma, St Louis, Mo) was added to give a final concentration of 0.1% and the contents of the wells were removed by vigorous pipetting and washing with sterile deionized H 2 O. Complete removal of MOs and Candida was confirmed using an inverted microscope. Serial dilutions from each well were made in sterile deionized H 2 O and cultured on Sabouraud dexterose agar plates at 37°C. The number of colony-forming units (cfu) was determined after 12 to 18 hours of incubation at 37°C. Macrophage candidacidal activity was calculated as:
([cfu control well−cfu experimental well]/ cfu control well)ϫ100
CYTOTOXICITY ASSAY
Adherent PMOs (2ϫ10 5 per well) in 96-well flat-bottom plates were stimulated with interferon gamma (100 U/mL) and LPS (1 µg/mL) for 16 hours and the activation medium was replaced with fresh medium. B16 melanoma cells were added to the wells at an MO to melanoma ratio of 20:1. Cells were then incubated at 37°C and supernatants were harvested 48 hours later. Macrophage-mediated cytotoxicity was then assayed by measuring the amount of lactate dehydrogenase released from lysed target cells according to the method of Decker and Lohmann-Mattes. 19 Specific lysis was calculated using the formula:
where A is the absorbance at 490 nm subtracted from background absorbance (medium alone); A (experimental) is the net absorbance of supernatant from wells containing activated macrophages and melanoma cells; A (spontaneous) represents the net absorbance by wells containing melanoma cells alone; and A (maximal) represents the net absorbance of melanoma cells that have been freezethawed to lyse all the cells, representing the total amount of lactate dehydrogenase that can be released from melanoma targets.
STATISTICAL ANALYSES
The data are presented as the mean±SE for control (n=10) and melanoma-bearing mice (n=10). Experiments were repeated 2 to 3 times. When comparing 2 groups, the student t test was used for parametric data and the Wilcoxon rank sum test was used for nonparametric data analysis. Calculations were performed using a statistical package (InStat for MacIntosh; GraphPad Software, San Diego, Calif).
(REPRINTED) ARCH SURG/ VOL 136, JULY 2001mL) for 24 hours and TNF-␣ production was measured by enzyme-linked immunosorbent assay. Figure 3 shows that PMOs from B16 melanoma-bearing mice had significantly less mean TNF-␣ production compared with controls (200± 38 vs 394 ± 34 pg/mL; PϽ.001).
MELANOMA GROWTH INCREASES PMO PGE 2 PRODUCTION
To determine the effects of melanoma growth on PMO PGE 2 production, PMOs from control and B16 melanoma-bearing mice were stimulated with LPS (1 µg/mL) for 24 hours and PGE 2 production was measured by immunoassay. Figure 4 shows that PMOs from B16 melanoma-bearing mice had significantly more basal PGE 2 production compared with controls (249 ± 17 vs 1368 ± 676 pg/mL; PϽ.003). Similarly, stimulated PGE 2 production was also increased in MOs from melanoma bearing mice compared with controls, but this did not reach statistical significance (5430±1149 vs 9337±3481 pg/mL; P=.3).
MELANOMA GROWTH DECREASES PMO CANDIDACIDAL ACTIVITY
Since the mediators tested above are critical MO effector mechanisms against microbial infections, we investigated the functional candidacidal capacity of PMOs from melanoma-bearing mice. Peritoneal macrophages from control and B16 melanoma-bearing mice were coincubated with C albicans as described and PMO killing of Candida was measured. Figure 5 shows that PMOs from B16 melanoma-bearing mice were significantly less able to kill Candida species in vitro compared with controls (44%±8.3% vs 67%±7.2%; PϽ.05).
MELANOMA GROWTH DECREASES PMO CYTOTOXICITY
To determine the effects of melanoma growth on PMO-mediated killing of B16 melanoma, PMOs from control and B16 melanoma-bearing mice were activated with LPS (1 µg/mL) and interferon gamma (100 U/mL) and PMO cytotoxicity was measured. Figure 6 shows that PMOs from melanoma-bearing mice had significantly decreased cytotoxicity against syngenic B16 melanoma targets compared with controls (2.3%±1.2% vs 27%±5%; PϽ.001).
COMMENT
The incidence of melanoma among white populations has increased dramatically over the last few decades. 2, 3 While many aspects of the immunobiology of melanoma are known, the basis for immunosuppression induced by melanoma and other tumors remains unclear. Tumor-induced immunosuppression results in defective cellular immune responses and probably contributes to an increased incidence of perioperative and infectious complications, poor responses to immunotherapy, and ultimately, accelerated tumor growth. 9 The MO plays an important role in immune regulation, tumor cytotoxicity, and microbicidal immune response. 20, 21 The antimicrobial capability of the MO is well documented, especially against facultative and obligate intracellular bacteria, protozoa, and fungi. 22 Several effector molecules are known to be important in MOmediated cytotoxicity and microbicidal activity. These include SO anion, NO, proteases, acid hydrolases, cationic proteins, and lysozymes. In addition, the MO secretes several cytokines, bioactive lipid products, and complement components that act in an autocrine and paracrine manner to modulate the immune response to a pathogen. 10 We have characterized in this murine melanoma model significant suppression in MO production of effector molecules and the impaired MO-mediated killing of melanoma targets and candidacidal mechanisms that result. Our study demonstrates that MOs from melanomabearing mice have significantly reduced production of major effector molecules, including NO, SO anion, and TNF-␣ production. Both basal and stimulated PGE 2 production were increased in MOs from melanomabearing mice. The functional consequences of these alterations were significant decreases in MO-mediated killing of melanoma targets in vitro and significant impairment of candidacidal mechanisms by MOs from melanoma-bearing mice. This study provides a comprehensive examination of effector molecules (NO, SO anion, and TNF-␣), suppressive molecule (PGE 2 ), and functional capacity (cytotoxicity and microbicidal mechanisms) in PMOs from melanoma-bearing mice. Other investigators, focusing on PMO functions, have demonstrated increased PGE 2 production and decreased cytotoxicity in MOs from tumor-bearing hosts. [23] [24] [25] [26] [27] It is possible that different results might be seen with other fixed MO populations. Human circulating monocytes and macrophages may exhibit different patterns than seen in this study. Further studies are required to elucidate these differences.
Our results may provide an explanation for the increased susceptibility to infections (especially fungal) in tumor-bearing hosts. Similarly, the defective MOmediated cytotoxicity against tumor targets may provide an explanation for ineffective responses to immunotherapy. Strategies aimed at reversing MO immunosuppression may prove useful adjuvants to immune therapy.
While not directly tested in this study, the inhibition of PGE 2 production may prove beneficial in reversing MO dysfunction, especially with the availability of selective cyclooxygenase inhibitors. 28 Current studies examine the mechanisms and cellular pathways involved in mediating the observed defects. In in vitro studies we have been able to reproduce some of the defects in MO function by coincubating MOs with a melanoma-conditioned medium. Preliminary characterization studies point to a secreted melanoma-derived protein that may mediate the observed suppression in vivo.
In summary, MOs from melanoma-bearing mice demonstrate significant defects in NO, SO anion, and TNF-␣ production. This was associated with increased PGE 2 production. Concomitantly, MO-mediated cytotoxicity and killing of Candida species were significantly decreased. Augmenting MO function or inhibit- 
